Trial Profile

Randomised, double blinded, placebo controlled, parallel group study to evaluate efficacy and safety of Depigoid Grass / Birch Mix in patients with allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 30 Sep 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Birch pollen allergy immunotherapy (Primary) ; Grass pollen allergy immunotherapy (Primary)
Indications Allergic asthma; Allergic rhinoconjunctivitis; Seasonal allergic rhinitis
Focus Therapeutic Use
Sponsors LETI Pharma GmbH

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com